ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,491, issued on Feb. 18, was assigned to INVENTISBIO Co. LTD. (Shanghai).
"EGFR inhibitors" was invented by Xing Dai (Shanghai) and Yueheng Jiang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, salts, solid forms, and pharmaceutical compositions that are related to EGFR inhibitors, such as N-(2-((2-(dimethylanino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide, as well as methods of preparing the same. Also provided herein are methods of using the compounds, salts, solid forms, and pharmaceutical compositions for the treatment of diseases or di...